0.5582 USD
+0.02 (+3.14%)
At close: Jan 30, 2026
0.55 USD
-0.01 (-1.47%)
After Hours: 1/30/2026, 8:23:46 PM
ChartMill assigns a Buy % Consensus number of 50% to VTGN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 3.8. This target is 580.67% above the current price.
- VTGN was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about VTGN.
- In the last month the buy percentage fell by 37 points. So the trust of analysts is decreasing.
- VTGN was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-12-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-12-17 | Jefferies | Downgrade | Buy -> Hold |
| 2023-12-07 | Jefferies | Upgrade | Hold -> Buy |
| 2023-11-14 | Stifel | Initiate | Buy |
| 2023-09-05 | Maxim Group | Maintains | Buy -> Buy |
| 2023-08-07 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-26 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-07-22 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-05-20 | Baird | Initiate | Outperform |
| 2021-02-18 | Jefferies | Initiate | Buy |
VISTAGEN THERAPEUTICS INC / VTGN FAQ
What is the price target for VTGN stock?
10 analysts have analysed VTGN and the average price target is 3.8 USD. This implies a price increase of 580.67% is expected in the next year compared to the current price of 0.5582.
Can you provide the consensus rating for VISTAGEN THERAPEUTICS INC stock?
The consensus rating for VISTAGEN THERAPEUTICS INC (VTGN) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for VISTAGEN THERAPEUTICS INC stock?
The number of analysts covering VISTAGEN THERAPEUTICS INC (VTGN) is 10.